Hui Chen Wu,Regina Santella
Hui Chen Wu
Context: Hepatocellular carcinoma (HCC) is one of the most common cancers in the world but with a striking geographical variation in incidence; most of the burden is in developing countries. This geographic variation in H...
Aleksandra Topic,Mila Ljujic,Dragica Radojkovic
Aleksandra Topic
Context: Alpha-1-antitrypsin (A1AT) is the most abundant liver-derived, highly polymorphic, glycoprotein in plasma. Hereditary deficiency of alpha-1-antitrypsin in plasma (A1ATD) is a consequence of accumulation of polyme...
Mona Abu El Makarem
Mona Abu El Makarem
Context: Primary liver cancer is one of the most common and deadly malignant neoplasms worldwide. The incidence and mortality rates for hepatocellular carcinoma (HCC) are virtually identical, reflecting the poor overall s...
Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma [0.03%]
射频消融治疗肝细胞癌的研究进展
Takashi Himoto,Kazutaka Kurokohchi,Seishiro Watanabe et al.
Takashi Himoto et al.
CONTEXTS: Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed. ...
Mario Uccello,Giulia Malaguarnera,Thea Corriere et al.
Mario Uccello et al.
Context: Studies on experimental animals have shown liver is a common target of chemical carcinogens; this might suggest that occupational exposure to chemicals is another risk factor for HCC. However, the relationship be...
Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: a case report [0.03%]
肝移植后同时发生肝细胞癌和胆管癌（碰撞瘤）的病例报告
Waleed Al Hamoudi,Hatem Khalaf,Naglaa Allam et al.
Waleed Al Hamoudi et al.
Coincidental occurrence of hepatocellular carcinoma (HCC) and cholangiocarcinoma, known as "collision tumors", within a cirrhotic liver is rare. Herein, we report a case of liver transplantation (LT) in a patient with such collision tumors....
Case Reports
Hepatitis monthly. 2012 Oct;12(10 HCC):e5871. DOI:10.5812/hepatmon.5871 2012
Is combination therapy for chronic hepatitis C toxic for cardiac function? [0.03%]
慢性丙型肝炎的联合疗法对心脏功能有毒副作用吗？
Ramzy Almawardy,Walid Elhammady,Nasser Mousa et al.
Ramzy Almawardy et al.
Background: Many types of cardiovascular complications such as; cardiac arrhythmias, impaired cardiac function, myocardial ischemia and decreased left ventricular function, have been attributed to interferon therapy. ...
Fatemeh Abdi
Fatemeh Abdi
Citation Analysis of Hepatitis Monthly by Journal Citation Report (ISI), Google Scholar, and Scopus [0.03%]
三种数据库中《肝炎月刊》的被引分析：JCR、Google Scholar和Scopus
Seyyed Mohammad Miri,Azam Raoofi,Zahra Heidari
Seyyed Mohammad Miri
Background: Citation analysis as one of the most widely used methods of bibliometrics can be used for computing the various impact measures for scholars based on data from citation databases. Journal Citation Reports (JCR...
Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study [0.03%]
伊朗 Zahedan 市人群乙肝表面抗原和抗丙肝抗体的血清流行病学调查
Alireza Ansari-Moghaddam,Mohammad Reza Ostovaneh,Batool Sharifi Mood et al.
Alireza Ansari-Moghaddam et al.
Background: There have been studies regarding the prevalence of hepatitis B surface antigen (HBsAg) and anti-hepatitis C antibody (HCVAb) in Iran. However, the majority of these have reported a variety of rates, depending...